We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

15 hedge funds and large institutions have $525K invested in Clovis Oncology, Inc. in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

85% less funds holding

Funds holding: 103 → 15 (-88)

98% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 90

99% less capital invested

Capital invested by funds: $42.9M → $525K (-$42.4M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
15
Holders Change
-88
Holders Change %
-85.44%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
90
Calls
$22K
Puts
–
Net Calls
+$22K
Net Calls Change
-$2.59M

Top Buyers

Rank Fund Capital Flow
1
STB
S&T Bank
Pennsylvania
+$13.2K
2
IA
IFP Advisors
Florida
+$33

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$12.1M
2
PAI
Palo Alto Investors
California
-$5.32M
3
BlackRock
BlackRock
New York
-$4.8M
4
QF
QVT Financial
New York
-$4.2M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
– -$63K -52,609 Closed
SPC
52
Sigma Planning Corp
Michigan
– -$62K -52,148 Closed
BRA
53
Bender Robert & Associates
California
– -$60K -50,000 Closed
CS
54
Credit Suisse
Switzerland
– -$56K -46,952 Closed
D.E. Shaw & Co
55
D.E. Shaw & Co
New York
– -$53K -44,924 Closed
WAM
56
Wolverine Asset Management
Illinois
– -$48K -40,516 Closed
Stifel Financial
57
Stifel Financial
Missouri
– -$46K -38,781 Closed
Osaic Holdings
58
Osaic Holdings
Arizona
– -$45K -38,505 Closed
BFM
59
Boothbay Fund Management
New York
– -$43K -36,350 Closed
Allspring Global Investments
60
Allspring Global Investments
North Carolina
– -$31K -26,156 Closed
TSS
61
Two Sigma Securities
New York
– -$31K -26,054 Closed
PPW
62
Pasadena Private Wealth
California
– -$30K -25,000 Closed
OCM
63
Objective Capital Management
Ohio
– -$29K -24,272 Closed
NFG
64
Norris Financial Group
South Carolina
– -$26.8K -22,516 Closed
US Bancorp
65
US Bancorp
Minnesota
– -$23K -19,687 Closed
Truist Financial
66
Truist Financial
North Carolina
– -$21K -17,290 Closed
Squarepoint
67
Squarepoint
New York
– -$20K -16,700 Closed
CA
68
Cetera Advisors
Colorado
– -$19K -16,330 Closed
Victory Capital Management
69
Victory Capital Management
Texas
– -$19K -16,075 Closed
EL
70
EMFO LLC
Florida
– -$19K -16,000 Closed
CG
71
Cutler Group
California
– -$17K -14,569 Closed
LPL Financial
72
LPL Financial
California
– -$17K -14,133 Closed
AFG
73
Allegheny Financial Group
Pennsylvania
– -$16K -13,950 Closed
EGM
74
Engineers Gate Manager
New York
– -$16K -13,406 Closed
NSEDCP
75
NJ State Employees Deferred Compensation Plan
New Jersey
– -$15K -13,000 Closed
1 2
3
4

CLVS Hedge Fund Activity: Q4 2022 in Review

15 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2022, worth a combined $525K — down 99% from $42.9M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of CLVS and 2 opened new positions — a net loss of 88 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was S&T Bank, adding an estimated $13.2K. The largest seller was Vanguard Group, exiting entirely with an estimated $12.1M sold.

  • 15 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2022, down from 103 in Q3 2022.
  • Funds reported $525K of Clovis Oncology, Inc. stock for Q4 2022, down 99% quarter-over-quarter.
  • 2 funds opened new Clovis Oncology, Inc. positions in Q4 2022 and 90 closed out, a net change of -88 holders.
  • The largest Clovis Oncology, Inc. buyer in Q4 2022 was S&T Bank, an estimated $13.2K added.
  • The largest Clovis Oncology, Inc. seller in Q4 2022 was Vanguard Group, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2022.